Q1 FY20 4C Investor Update with Andrew Ronchi
Wearable Tech News
UK-based ASM Technologies signs three-year myViSafe deal valued at $550k AUD
Appendix 4D and Half Year Financial Report Dec 2018
Appendix 4C – Quarterly December 2018
[AUDIO] Q2 FY19 4C Investor Update with Andrew Ronchi
dorsaVi signs large Work Right project
[AUDIO] Q1 FY19 4C Investor Update with Andrew Ronchi and Matthew May
Appendix 4C – Quarterly September 2018
dorsaVi 4E 2018 Announcement
APPENDIX 4E – PRELIMINARY FINANCIAL REPORT JUN 2018
dorsaVi CEO featured on Proactive Investors
Appendix 4C – Quarterly June 2018
[AUDIO] Q4 FY18 4C Investor Update with Andrew Ronchi & Matthew May
dorsaVi launches Professional Suite for the clinical market in USA
New patent strengthens dorsaVi’s IP and leadership position in medical grade wearables
dorsaVi USA signs master pilot agreement with AIG affiliate
[AUDIO] Q3 FY18 4C Investor Update with Andrew Ronchi & Matthew May
New Low Back Pain Treatment Trial To Adopt dorsaVi Technology
[AUDIO] Q1 FY18 4C Investor Update with Andrew Ronchi
Business IQ interview with dorsaVi CEO Dr Andrew Ronchi
[AUDIO] Q4 FY17 4C Investor Update with Andrew Ronchi
[AUDIO] Q3 4C Investor Update with Andrew Ronchi
Investor Update Webcast – Jan 30, 2017
Show More